Cardiomyopathies in children and adolescents: aetiology, management, and outcomes in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Registry
Juan Pablo Kaski,Gabrielle Norrish,Juan Ramon Gimeno Blanes,Philippe Charron,Perry Elliott,Luigi Tavazzi,Michal Tendera,Cécile Laroche,Aldo P Maggioni,Anwar Baban,Diala Khraiche,Lidia Ziolkowska,Giuseppe Limongelli,Tiina Ojala,Matthias Gorenflo,Aris Anastasakis,Shaimaa Mostafa,Alida L P Caforio,R Ferrari,A Alonso,J Bax,C Blomström-Lundqvist,S Gielen,P Lancellotti,A P Maggioni,N Maniadakis,F Pinto,F Ruschitzka,L Tavazzi,P Vardas,F Weidinger,U Zeymer,A Vahanian,A Budaj,N Dagres,N Danchin,V Delgado,J Emberson,O Friberg,C P Gale,G Heyndrickx,B Iung,S James,A P Kappetein,A P Maggioni,N Maniadakis,K V Nagy,G Parati,A-S Petronio,M Pietila,E Prescott,F Ruschitzka,F Van de Werf,F Weidinger,U Zeymer,C P Gale,B Beleslin,A Budaj,O Chioncel,N Dagres,N Danchin,J Emberson,D Erlinge,M Glikson,A Gray,M Kayikcioglu,A P Maggioni,K V Nagy,A Nedoshivin,A-P Petronio,J W Roos-Hesselink,L Wallentin,U Zeymer,B A Popescu,D Adlam,A L P Caforio,D Capodanno,M Dweck,D Erlinge,M Glikson,J Hausleiter,B Iung,M Kayikcioglu,P Ludman,L Lund,A P Maggioni,S Matskeplishvili,B Meder,K V Nagy,A Nedoshivin,D Neglia,A A Pasquet,J W Roos-Hesselink,F J Rossello,S M Shaheen,A Torbica,A lida Caforio,Juan Ramon Gimeno Blanes,P hilippe Charron,P erry Elliott,Juan Pablo Kaski,Aldo P Maggioni,Luigi Tavazzi,Michal Tendera,S Komissarova,N Chakova,S Niyazova,S Mostafa,J Pihkala,T Ojala,A Hiippala,T Jarvinen,D Bonnet,D Khraiche,I Szezepanski,M Gorenflo,R Arnold,S Uhl,V Ziesenitz,A Jung,E Roesch,M Ilina,J P Kaski,G Norrish,E Field,A Anastasakis,K Ritsatos,V Vlagkouli,S Rammos,G Kourelis,G Vagenakis,G Papadopoulos,A Giannakopoulou,E Karanasios,P Papachristou,G Servos,E Biagini,A Corsini,C Gagliardi,M Graziosi,A Milandri,L Ragni,S Palmieri,R Calabro,G Pacileo,M G Russo,G Limongelli,M Caiazza,A Cirillo,G Del Giorno,A Esposito,S Tramonte,F Valente,R Gravino,T Marrazzo,D Masarone,V Pazzanese,A Rea,M Rubino,F Drago,A Baban,G Sinagra,C Carriere,M Merlo,F Ramani,M Bobbo,B Dagata,A Kavoliuniene,A Krivickiene,E Tamuleviciute-Prasciene,M Viezelis,F W Asselbergs,N De Jonge,J H Kirkels,J Van Der Heijden,L Van Laake,A Sammani,J Ajuluchukwu,A Olusegun-Joseph,E Ekure,G Brzezinska-Rajszys,L Ziolkowska,A Boruc,E Plodzien,E Zaklyazminskaya,S Dzemeshkevich,E Kolbasova,N Kotlukova,V Rusinova,A Cequier,J Salazar-Mendiguchia,J Gonzalez,N Manito,P Garcia-Pavia,A Briceno,M Cobo-Marcos,F Dominguez,J R Gimeno Blanes,F J Castro,C Munoz Esparza,M Sabater Molina,M Sorli García,D Lopez Cuenca,P L Sanchez Fernandez,E Villacorta,B Plata,C Avila,L Bravo,E Diaz-Pelaez,M Gallego-Delgado,L Garcia-Cuenllas,J E Lopez-Haldon,E M Cantero Perez,M L Pena Pena,the EORP Paediatric Cardiomyopathy Registry Investigators
DOI: https://doi.org/10.1093/eurheartj/ehae109
IF: 39.3
2024-03-02
European Heart Journal
Abstract:Childhood-onset cardiomyopathies are rare and poorly characterized. This study examined the baseline characteristics and 1-year follow-up of children with cardiomyopathy in the first European Cardiomyopathy Registry. Prospective data were collected on individuals aged 1–<18 years enrolled in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis long-term registry (June 2014–December 2016). A total of 633 individuals aged ≤18 years with hypertrophic [HCM; n = 388 (61.3%)], dilated [DCM; n = 206 (32.5%)], restrictive [RCM; n = 28 (4.4%)], and arrhythmogenic right ventricular cardiomyopathy [ARVC; n = 11 (1.7%)] were enrolled by 23 referral centres in 14 countries. Median age at diagnosis was 4.0 [interquartile range (IQR) 0–10] years, and there was a male predominance [ n = 372 (58.8%)] across all subtypes, with the exception of DCM diagnosed <10 years of age; 621 (98.1%) patients were receiving cardiac medication and 80 (12.6%) had an implantable cardioverter-defibrillator. A total of 253 patients (253/535, 47.3%) had familial disease. Genetic testing was performed in 414 (67.8%) patients with a pathogenic or likely pathogenic variant reported in 250 (60.4%). Rare disease phenocopies were reported in 177 patients (28.0%) and were most frequent in patients under 10 years [142 (30.9%) vs. 35 (19.6%); P = .003]. Over a median follow-up of 12.5 months (IQR 11.3–15.3 months), 18 patients (3.3%) died [HCM n = 9 (2.6%), DCM n = 5 (3.0%), RCM n = 4 (16.0%)]. Heart failure events were most frequent in RCM patients (36.0%). The findings confirm the heterogeneous aetiology of childhood cardiomyopathies and show a high frequency of familial disease. Outcomes differed by cardiomyopathy subtype, highlighting a need for disease-specific evaluation and treatment. Characteristics and outcomes of paediatric onset cardiomyopathy in a European population. HCM, hypertrophic cardiomyopathy; DCM, dilated cardiomyopathy; RCM, restrictive cardiomyopathy; ARVC, arrhythmogenic right ventricular cardiomyopathy.
cardiac & cardiovascular systems